Short-Term Amiodarone After AF Ablation Won't Block Late AFShort-Term Amiodarone After AF Ablation Won't Block Late AF
In the AMIO-CAT study, an eight-week course of amiodarone after AF ablation blocked some forms of AF in the short term but didn't cut the recurrence risk over six months. Heartwire (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 8, 2014 Category: Consumer Health News Tags: Cardiology News Source Type: news
PVC Reduction by Amiodarone in HF Could Boost LVEFPVC Reduction by Amiodarone in HF Could Boost LVEF
Dyssynchrony caused by frequent premature ventricular contractions may be alleviated by drug suppression of PVCs, with a benefit on ventricular function. Heartwire (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 24, 2014 Category: Consumer Health News Tags: Cardiology News Source Type: news
Toxic Spill in West Virginia: Tox on the Web
Chemical Leak in West Virginia: On her Wired Science blog Elemental, @deborahblum tries to track down information about 4-methylcyclohexane methanol (MCHM), a “detergent” (foaming agent) used for washing coal that leaked from a storage tank into West Virginia’s Elk River on Thursday. Not much is known about the toxicology and risk of MCHM, except that it is an irritant. In the meantime, hundreds of thousands of West Virginia residents have been advised to stop drinking and bathing in tap water. Blum makes the important point that, although at this point MCHM does not seem to be overwhelmingly toxic, not...
Source: The Poison Review - January 12, 2014 Category: Toxicology Authors: Leon Tags: Medical amiodarone carbon monoxide toxicity child abuse dolphins elk river hyperbaric oxygen methylcyclohexane puffer fish toxic leak west virginia Source Type: news
Phlebitis in Amiodarone AdministrationPhlebitis in Amiodarone Administration
Intravenous amiodarone is an important treatment for arrhythmias, but peripheral infusion is associated with direct irritation of vessel walls and phlebitis. American Journal of Critical Care (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 4, 2013 Category: Consumer Health News Tags: Critical Care Journal Article Source Type: news
Lipid rescue therapy can cause lab errors
3 out of 5 stars
Caution with interpreting laboratory results after lipid rescue therapy. Punja M et al. Am J Emerg Med 2013 Aug 8 [Epub ahead of print]
No abstract available
This short case report from Emory University and the Georgia Poison Center makes the point that administering lipid rescue therapy (LRT) may affect laboratory results in ways that may be unanticipated. In the case, a 54-year-old man who ingested a mixed overdose of diphenhydramine, amitriptyline and acetaminophen. His initial aspartate aminotransferase level (measured on a Siemens Vista 1500 analyzer) was 138 U/L. After 20% IV lipids were given, a re...
Source: The Poison Review - August 22, 2013 Category: Toxicology Authors: Leon Tags: Medical aspartate aminogransferase AST erroneous lab values laboratory error lipid rescue therapy Source Type: news
Oral Propafenone May Help AF Quickly and CheaplyOral Propafenone May Help AF Quickly and Cheaply
Oral propafenone may be as effective as IV amiodarone - but faster - at converting recent-onset atrial fibrillation (AF) to sinus rhythm, new research suggests. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 19, 2013 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
Amiodarone-cancer link reemerges in observational study
The widely used antiarrhythmic appeared to increase the risk of cancer, especially in men, in a retrospective cohort study. Observers say the findings are only hypothesis-generating and would need prospective studies to confirm. (Source: theHeart.org)
Source: theHeart.org - April 11, 2013 Category: Cardiology Source Type: news
Amiodarone Linked to Increased Cancer Risk in MenAmiodarone Linked to Increased Cancer Risk in Men
The widely used antiarrhythmic drug appears to increase the risk for cancer in men in a dose-dependent manner. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Heart Drug Linked to Cancer
(Ivanhoe Newswire) – For people living with heart arrhythmias, medications to control the unstable heart beat become a part of everyday life. However, one common arrhythmia drug may do patients more harm than good. A recent Taiwanese study discovered the medication amiodarone may increase the risk of cancer, especially in men and individuals with high amounts of the drug in their system. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - April 10, 2013 Category: Consumer Health News Source Type: news
Common Heart Drug Associated With Increased Cancer Risk
A drug known as amiodarone, used to treat heartbeat irregularities, could raise a person's cancer risk, according to new research published in the journal Cancer. The study reveals that the risk, which the investigators described as "borderline significantly increased", is more prevalent in men and people who take greater doses of amiodarone. Amiodarone was approved for use in 1985 for the treatment of arrhythmias, or irregular heartbeats. The medication is fat-soluble and breaks down slowly, leaving large amounts to build up in soft tissues after a long-term treatment period... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 8, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Amiodarone Linked to Cancer Risk in Men (CME/CE)
(MedPage Today) -- The risk of cancer was increased in men taking the antiarrhythmia drug amiodarone (Nexterone), particularly in those with extensive exposure to the drug, a retrospective study found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 8, 2013 Category: Cardiology Source Type: news
Arrhythmia Drug May Increase Cancer Risk
One of the most widely used medications to treat arrhythmias may increase the risk of developing cancer, especially in men and people exposed to high amounts of the drug. That is the conclusion of a new retrospective study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results indicate that a potential link between amiodarone and cancer warrants further investigation. Amiodarone was approved in 1985 for the treatment of arrhythmias, or irregular heartbeats... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 8, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Study Links Amiodarone to Cancer Risk in Men (CME/CE)
(MedPage Today) -- The risk of cancer was increased in men taking the antiarrhythmia drug amiodarone (Nexterone), particularly in those with extensive exposure to the drug, a retrospective study found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 8, 2013 Category: Cardiology Source Type: news
Arrhythmia drug may increase cancer risk
(Wiley) One of the most widely used medications to treat arrhythmias may increase the risk of developing cancer, especially in men and people exposed to high amounts of the drug. That is the conclusion of a new retrospective study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results indicate that a potential link between amiodarone and cancer warrants further investigation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 8, 2013 Category: Global & Universal Source Type: news
Updated national IV monograph on Amiodarone hydrochloride
Source: Medusa
Area: News
An updated IV monograph on Amiodarone hydrochloride is now available from the NHS injectable medicines guide website (Medusa). Please see the link below for access (registration required). (Source: NeLM - News)
Source: NeLM - News - February 20, 2013 Category: Drugs & Pharmacology Source Type: news
